Jeffrey Cooper MBA ’80 has been appointed to the board of directors for Nexcella, Inc., a Los Angeles based clinical-stage biopharmaceutical company developing novel cell therapies for oncology. Cooper has over 30 years of experience in the pharmaceutical industry, including as CFO of KaloBios Pharmaceuticals, Inc., VP of finance at Matrix Pharmaceuticals, and corporate controller at Foundation Health Systems.

13 Nov 2023